Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-15
2008-07-15
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S339000, C546S268100, C546S304000, C514S336000
Reexamination Certificate
active
10500156
ABSTRACT:
Provided are novel compounds having an inhibitory activity against production or secretion of β-amyloid protein. They embrace compounds represented by the following formula (1):and capable of being replaced with a variety of substituents; and salts thereof, and solvates of any one of them.
REFERENCES:
patent: 4055652 (1977-10-01), Walker
patent: 4116665 (1978-09-01), Krumkalns
patent: 4157399 (1979-06-01), Sauter
patent: 4257954 (1981-03-01), Schmidt et al.
patent: 4675316 (1987-06-01), Chan
patent: 6689909 (2004-02-01), Butlin et al.
patent: 2005/0234109 (2005-10-01), Yasukouchi et al.
patent: 4215437 (1993-11-01), None
patent: 112 (1978-12-01), None
patent: 752 (1979-02-01), None
patent: 46658 (1982-03-01), None
patent: 117485 (1984-09-01), None
patent: 153657 (1985-09-01), None
patent: 2509725 (1983-01-01), None
patent: 1554299 (1979-10-01), None
patent: 55-33473 (1980-03-01), None
patent: 62-39563 (1987-02-01), None
patent: 6-25168 (1994-02-01), None
patent: 6-56780 (1994-03-01), None
patent: 9-95444 (1997-04-01), None
patent: WO 93/25536 (1993-12-01), None
patent: WO 96/41799 (1996-12-01), None
patent: 98/38156 (1998-09-01), None
patent: 00 50391 (2000-08-01), None
patent: 01 70677 (2001-09-01), None
patent: 02/081433 (2002-10-01), None
patent: 02/081435 (2002-10-01), None
patent: 03 013527 (2003-02-01), None
patent: 03 014075 (2003-02-01), None
patent: 03/018543 (2003-03-01), None
patent: 03 053912 (2003-07-01), None
patent: WO 03/055850 (2003-07-01), None
patent: WO 03/059335 (2003-07-01), None
patent: 03 066592 (2003-08-01), None
patent: 03 093251 (2003-11-01), None
patent: 03 093252 (2003-11-01), None
patent: 03 093253 (2003-11-01), None
patent: 03 093264 (2003-11-01), None
patent: 03 103660 (2003-12-01), None
patent: WO 2004/017977 (2004-03-01), None
patent: WO 2004/031137 (2004-04-01), None
patent: WO 2004/031138 (2004-04-01), None
patent: WO 2004/031139 (2004-04-01), None
patent: 2004 039370 (2004-05-01), None
patent: 2004 039800 (2004-05-01), None
Kurahashi et al., 1994, CAS: 121:3287.
Anders et al., 1989, CAS:110:74541.
Traynelis et al., 1974, CAS: 80:14814.
Cai, Xiao-Dan et al. “Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein Precursor”, Science, vol. 259, pp. 514-516 Jan. 22, 1993.
Gravina, Stephen A. et al. “Amyloid β Protein (Aβ) in Alzheimer's Disease Brain”, The Journal of Biological Chemistry, vol. 270, No. 13, pp. 7013-7016 Mar. 31, 1995.
Vassar, Robert et al. “β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE”, Science, vol. 286, pp. 735-741 Oct. 22, 1999.
Hussain, I. et al. “ASP1 (BACE2) Cleaves the Amyloid Precursor Protein at the β-Secretase Site”, Molecular and Cellular Neuroscience, vol. 16, pp. 609-619 2000.
Wolfe, Michael et al. “Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity”, Nature, vol. 398, pp. 513-517 Apr. 8, 1999.
Wolfe, Michael “Secretase Targets for Alzheimer's Disease: Identification and Therapeutic Potential”, Journal of Medicinal Chemistry, vol. 44, No. 13, pp. 2039-2060 Jun. 21, 2001.
Anders, Ernst et al. “‘Ferngesteuerte’ nucleophile Eigenschaften der Anionen einiger 4-Alkylpyridine: AM 1- und MNDO-Berechnungen sowie experimentelle Untersuchungen”, Chem. Ber., vol. 122, pp. 105-111 1989.
Skarzewski, J., Simple preparation of enantiometric Michael adducts of thiophenol to chalcones, Tetrahedron: Asymmetry, Jul. 30, 2001, vol. 12, No. 13, pp. 1923 to 1928.
Ishibashi, Hiroyuki, Lewis acid-promoted alkylations of arenes and 1-trimethylsilylalkynes with beta-chloro-beta-thiopropanoic esters, Chemical & Pharmaceutical Bulletin, 1991, vol. 39, No. 5, pp. 1148 to 1151.
Karavan, V.S., Isoselectivity relation in the halophilic reaction of alpha-chlorodesyl aryl sulfones with sodium thiophenolate, Zhurnal Organicheskoi Khimii, 1989, vol. 25, No. 5, pp. 905 to 910.
Muehlstaedt, M., Cyclization reaction of beta, gamma-unsaturated derivatives of carbonic acid, Journla fuer Praktische Chemie, 1986, vol. 328, No. 3, pp. 309 to 313.
Fournier, Jean Paul, Hypolipernic activity of 2-hydroxyalkyl and 3-hydroxyalkyl phenyl sulfones., European Journal of Medicinal Chemistry, 1982, vol. 17, No. 1, pp. 53 to 58.
Walker, Keith A.M., A convenient preparation of thioethers from alcohols, Tetrahedron Letters, 1977, No. 51, pp. 4475 to 4478.
Lapkin, I.I., Reactions of halo metal alcoholates, Khimiya Geterotsiklicheskikh Soedinenii, 1968, No. 1, pp. 53 to 57.
Panteleimonov, A.V., Addition of nucleophilic agents to 1-aryl-2-trifluoro-methylsulfonylethylenes, Zhurnal Obshchei Khimii, 1966, vol. 36, No. 11, pp. 1976 to 1980.
Wragg, A.H., Rearrangement of sulfinic esters, J. Chem. Soc., 1958, pp. 3603 to 3605.
Cranham, J.E., Toxicity of organic sulfides to the eggs and larvae of the two-spotted spider mite, J. Sci. Food Agr., 1958, vol. 9, pp. 147 to 150.
Krzysztof Wojciechowski, “Synthesis of Nitrobenzophenones from Nitro-α-Sulfonyldiphenylmethane Derivatives”, Synthetic Communications, 27(1), 1997, pp. 135-144.
Eric K. Yau, et al., “Synthesis of Complex 6′-Alkynyl-6′-dethia Nucleoside Analogues of S-Adenosylhomocysteine as Potential Inhibitors of Methyltransferases”, Journal of Organic Chemistry, vol. 55, No. 10, American Chemical Society 1990, pp. 3147-3158.
I. I. Lapkin, et al., “Reactions of halogen metal alcoholates, XXI, New method of synthesizing sulfides of thiophenic series”, Khimiya Geterotsiklicheskih Soedinenii, No. 1, 1968, pp. 52-57 (with partial English translation).
U.S. Appl. No. 10/561,838, filed Dec. 22, 2005, Kubota et al.
Ibro Tabakovic, et al., “The Alkylation of Coumarin at C-3 of4-Hydroxycoumarin”, Organic Preparations and Procedures International, vol. 29, No. 2, Apr. 1997, pp. 223-226.
Ito Masayuki
Kubota Hideki
Miyauchi Satoru
Saito Masanori
Yasukouchi Takanori
Daiichi Pharmaceutical Co. Ltd.
Shiao Rei-tsang
LandOfFree
β-amyloid protein production/secretion inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with β-amyloid protein production/secretion inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and β-amyloid protein production/secretion inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3954979